Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
In Lilly patent spat, appeals court revives $177M verdict to Teva
The legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva gaining favor on appeal after a 2023 defeat.
Fraiser Kansteiner
Apr 17, 2026 10:16am
Lilly answers FDA's call for more Foundayo safety information
Apr 16, 2026 9:43am
Lilly told to gather more safety info on obesity launch Foundayo
Apr 14, 2026 4:08pm
Lilly touts Jaypirca fixed-duration win in ‘ambitious’ CLL trial
Apr 13, 2026 10:16am
Vanda tests motion sickness drug Nereus in GLP-1 patients
Apr 9, 2026 2:56pm
J&J's Tremfya retakes TV drug ad spending crown from AbbVie
Apr 8, 2026 11:44am
